Gli integratori alimentari non sostituiscono una dieta variata ed equilibrata, ma possono affiancarla quando esiste un fabbisogno specifico
Acknowledgements Medical writing and editorial support were provided by Nicole Cash, PhD, and Abbey Pearson, MSci, of Axis, a division of Spirit Medical Communications Group Limited (and were funded by Novo Nordisk Inc.) in accordance with Good Publication Practice 3 (GPP3) guidelines ( Ethics declarations Funding This trial and medical writing support for the publication were funded by Novo Nordisk A/S, Sborg, Denmark
mesoestetic Pharma Group S.L
By activating both GIP and GLP-1 receptors, tirzepatide: Enhances insulin secretion in response to elevated blood glucose levels Suppresses glucagon release , reducing hepatic glucose production Slows gastric emptying , promoting satiety and reducing appetite Acts on brain appetite centres , helping to reduce caloric intake Common adverse effects include nausea, diarrhoea, decreased appetite, vomiting, constipation, and abdominal discomfort
The development of GLP-1 medications like Ozempic/Wegovy (semaglutide) and GIP/GLP-1 agonists like Mounjaro/Zepbound (tirzepatide) have been game changers when it comes to treating type 2 diabetes and obesity
The underlying issue - insulin resistance - doesnt disappear when the medication stops
